LH Test

LH (luteinizing hormone) does not get nearly as much attention as testosterone or estrogen, but without it, neither would exist in adequate amounts. LH is the pituitary's direct instruction to the gonads: make steroids, mature that egg, release it, sustain the pregnancy. It operates differently in men and women, on different timescales and in different rhythms, yet in both sexes it sits at the center of reproductive health. Understanding what your LH level means, and what it does not mean on its own, is one of the more underappreciated pieces of a complete hormonal picture.

LH is a gonadotropin, a class of hormones produced by the anterior pituitary gland that act directly on the gonads. Like FSH, it is released as part of the hypothalamic-pituitary-gonadal (HPG) axis, a feedback loop running from the brain to the reproductive organs and back. LH is secreted in pulses, not a steady stream, and the frequency and amplitude of those pulses matter enormously for downstream effects. It acts by binding to a receptor called LHCGR, which it shares with human chorionic gonadotropin (hCG), the hormone detected in pregnancy tests. This shared receptor is why hCG can substitute for LH in certain clinical settings, such as triggering ovulation during fertility treatment.

In men, LH has one primary job: it travels to the testes and binds to Leydig cells, the specialized cells responsible for producing testosterone. This testosterone serves two purposes. It enters the bloodstream to support secondary sexual characteristics, libido, and general male physiology, and it also saturates the local testicular environment at concentrations roughly 100 times higher than circulating blood levels, which is necessary for full sperm production. LH also regulates Leydig cell proliferation, differentiation, and even their circadian rhythm, helping to maintain the stable hormonal environment that continuous spermatogenesis requires.

In women, LH plays a more dynamic, cycle-driven role. During the follicular phase, LH stimulates theca cells in the ovary to produce androgens, which granulosa cells then convert into estradiol under FSH's direction. This androgen supply is essential: without adequate LH-driven input, estradiol production falls short and follicle development stalls. Then, at mid-cycle, something dramatic happens. LH surges to a peak, and that surge is the direct trigger for final egg maturation and ovulation. After ovulation, LH sustains the corpus luteum, the temporary structure that forms from the ruptured follicle and produces the progesterone needed to prepare the uterine lining for implantation.

What happens when LH is out of range depends heavily on direction and context. The table below maps the key clinical patterns:

One nuance worth knowing: elevated LH in a man does not mean more testosterone. It usually means the opposite. When the testes fail to respond, the pituitary compensates by producing more LH in an attempt to get a response that cannot come. High LH paired with low testosterone is a signal of primary testicular failure, not of hormonal abundance.

The biology of LH balance in men and women also differs in timescale. In men, the system aims for stability: LH drives a relatively constant androgen milieu to support continuous sperm production. In women, the system is cyclical by design. Small deviations, a blunted surge, a shortened luteal phase, a chronically elevated baseline, each carry specific clinical consequences at different points in the cycle. This is why an LH result interpreted without knowing where a woman is in her cycle can be misleading or even meaningless.

There is also an interesting intersection between LH and bone biology. Research has found that osteocalcin, a hormone secreted by bone, regulates testosterone production through a pathway involving the testes, suggesting the reproductive and skeletal systems communicate more directly than previously thought. This pancreas-bone-testis axis represents an emerging area of research into how LH-driven steroidogenesis is influenced by signals from outside the HPG axis entirely, though clinical implications remain to be established.

Environmental factors also matter. Organochlorine compounds, a class of persistent environmental chemicals, have been shown to suppress steroid hormone biosynthesis in Leydig cells by interfering with the signaling cascade downstream of LH. Separately, leptin secreted from the testicular microenvironment has been found to modulate Leydig cell function through hedgehog signaling. These findings suggest that LH levels alone may not capture the full picture of LH action: even normal LH can fail to drive adequate testosterone if local cellular signaling is disrupted.

What You Can Do

As with FSH, the interventions with the strongest evidence base are pharmacological rather than lifestyle-based. The research supports the following clinical applications:

• For men with hypogonadotropic hypogonadism (low LH from a pituitary or hypothalamic problem): treatment with GnRH or hCG (which acts on the same receptor as LH) can restore testosterone production and spermatogenesis. This is an established and effective approach.
• For women undergoing ovarian stimulation who are poor responders or older: adding supplemental LH activity to FSH protocols has been shown to improve estradiol production, oocyte yield, and pregnancy rates in selected patients. The benefit is most clearly established in women with reduced LH action or hypogonadotropic hypogonadism.
• For women with PCOS: the underlying problem involves excessive LH pulsatility driving androgen overproduction. Management approaches target the upstream driver (GnRH pulse frequency) rather than LH directly.
• For very deep LH suppression during assisted reproduction: some evidence links profound suppression to higher early pregnancy loss, though data are mixed and clinical protocols vary. This remains an active area of investigation.

The research provided does not include studies examining whether lifestyle interventions such as diet, exercise, or sleep directly modify LH levels in ways proven to improve clinical outcomes.

Questions to Ask Your Doctor

1. My LH is elevated but my testosterone is low. Does that mean the problem is in my testes rather than my pituitary, and how does that change my treatment options?
2. If I have low LH and low testosterone, what is the most likely cause, and is there a treatment that addresses the root signal rather than just replacing testosterone?
3. For women with irregular cycles or anovulation: has my LH been measured at the right point in my cycle, and does my LH-to-FSH ratio suggest PCOS as a possible explanation?
4. If I am undergoing ovarian stimulation: would adding LH activity to my protocol be appropriate given my age or response history, and what does the evidence show for someone in my situation?
5. Could environmental exposures or other hormonal factors, such as leptin or bone-derived hormones, be interfering with how my cells respond to LH even if my LH level appears normal?